Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339:285–291

CAS  Article  Google Scholar 

Vukusic S, Hutchinson M, Hours M, Moreau T, Cortinovis-Tourniaire P, Adeleine P et al (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127(Pt 6):1353–1360

Article  Google Scholar 

Vukusic S, Ionescu I, Cornu C, Bossard N, Durand-Dubief F, Cotton F et al (2020) Oral nomegestrol acetate and transdermal 17-beta-estradiol for preventing post-partum relapses in multiple sclerosis: the POPARTMUS study. Mult Scler 27:1458–1463

Article  Google Scholar 

Hughes SE, Spelman T, Gray OM, Boz C, Trojano M, Lugaresi A et al (2014) Predictors and dynamics of postpartum relapses in women with multiple sclerosis. Mult Scler 20:739–746

Article  Google Scholar 

Fragoso YD, Boggild M, Macias-Islas MA, Carra A, Schaerer KD, Aguayo A et al (2013) The effects of long-term exposure to disease-modifying drugs during pregnancy in multiple sclerosis. Clin Neurol Neurosurg 115:154–159

Article  Google Scholar 

Hellwig K, Haghikia A, Rockhoff M, Gold R (2012) Multiple sclerosis and pregnancy: experience from a nationwide database in Germany. Ther Adv Neurol Disord 5:247–253

Article  Google Scholar 

Alroughani R, Alowayesh MS, Ahmed SF, Behbehani R, Al-Hashel J (2018) Relapse occurrence in women with multiple sclerosis during pregnancy in the new treatment era. Neurology 90:e840–e846

Article  Google Scholar 

Bsteh G, Algrang L, Hegen H, Auer M, Wurth S, Di Pauli F et al (2020) Pregnancy and multiple sclerosis in the DMT era: a cohort study in Western Austria. Mult Scler 26:69–78

Article  Google Scholar 

Berenguer-Ruiz L, Gimenez-Martinez J, Palazón-Bru A, Sempere AP (2019) Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy. J Neurol 266:2512–2517

CAS  Article  Google Scholar 

Finkelsztejn A, Fragoso YD, Ferreira MLB, Lana-Peixoto MA, Alves-Leon SV, Gomes S et al (2011) The Brazilian database on pregnancy in multiple sclerosis. Clin Neurol Neurosurg 113:277–280

CAS  Article  Google Scholar 

Jesus-Ribeiro J, Correia I, Martins AI, Fonseca M, Marques I, Batista S et al (2017) Pregnancy in Multiple Sclerosis: a Portuguese cohort study. Mult Scler Relat Disord 17:63–68

Article  Google Scholar 

Langer-Gould A, Smith JB, Albers KB, Xiang AH, Wu J, Kerezsi EH et al (2020) Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort. Neurology 94:e1939–e1949

Article  Google Scholar 

Vukusic S, Durand-Dubief F, Benoit A, Marignier R, Frangoulis B, Confavreux C (2015) Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis. Mult Scler 21:953–955

CAS  Article  Google Scholar 

Portaccio E, Moiola L, Martinelli V, Annovazzi P, Ghezzi A, Zaffaroni M et al (2018) Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: maternal risks. Neurology 90:e832–e839

Article  Google Scholar 

Canibaño B, Deleu D, Mesraoua B, Melikyan G, Ibrahim F, Hanssens Y (2020) Pregnancy-related issues in women with multiple sclerosis: an evidence-based review with practical recommendations. J Drug Assess 9:20–36

Article  Google Scholar 

de Seze J, Chapelotte M, Delalande S, Ferriby D, Stojkovic T, Vermersch P (2004) Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler J 10:596–597

Article  Google Scholar 

Avila-Ornelas J, Avila M, Stosic M, Robles L, Prieto PG, Hutton GJ et al (2011) The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis. Int J MS Care 13:91–93

Article  Google Scholar 

Hellwig K, Beste C, Schimrigk S, Chan A (2009) Immunomodulation and postpartum relapses in patients with multiple sclerosis. Ther Adv Neurol Disord 2:7–11

Article  Google Scholar 

Brandt-Wouters E, Gerlach OHH, Hupperts RMM (2016) The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis. Int J Gynaecol Obstet 134:194–196

CAS  Article  Google Scholar 

Rosa GR, O’Brien AT, de Nogueira EAG, de Carvalho VM, Paz SC, Fragoso YD (2018) There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis. Arq Neuropsiquiatr 76:361–366

Article  Google Scholar 

Horvat Ledinek A, Brecl Jakob G, Jerše J, Ruška B, Pavičić T, Gabelić T et al (2020) Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis. Mult Scler Relat Disord 38:101519

Article  Google Scholar 

Winkelmann A, Rommer PS, Hecker M, Zettl UK (2018) Intravenous immunoglobulin treatment in multiple sclerosis: a prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period. CNS Neurosci Ther 25:78–85

Article  Google Scholar 

Portaccio E, Ghezzi A, Hakiki B, Sturchio A, Martinelli V, Moiola L et al (2014) Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. J Neurol Neurosurg Psychiatry 85:845–850

Article  Google Scholar 

Vukusic S, Casey R, Rollot F, Brochet B, Pelletier J, Laplaud D-A et al (2020) Observatoire Français de la Sclérose en Plaques (OFSEP): a unique multimodal nationwide MS registry in France. Mult Scler 26:118–122

Article  Google Scholar 

Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ (1992) EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 55:671–676

CAS  Article  Google Scholar 

Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302

Article  Google Scholar 

Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T (2006) Variable selection for propensity score models. Am J Epidemiol 163:1149–1156

Article  Google Scholar 

Karim ME, Pellegrini F, Platt RW, Simoneau G, Rouette J, de Moor C. The use and quality of reporting of propensity score methods in multiple sclerosis literature: a review. Mult Scler. 2020;1352458520972557

Simoneau G, Pellegrini F, Debray TP, Rouette J, Muñoz J, Platt RW et al (2022) Recommendations for the use of propensity score methods in multiple sclerosis research. Mult Scler. https://doi.org/10.1177/13524585221085732

Article  PubMed  PubMed Central  Google Scholar 

Zhao L, Claggett B, Tian L, Uno H, Pfeffer MA, Solomon SD et al (2016) On the restricted mean survival time curve in survival analysis. Biometrics 72:215–221

Article  Google Scholar 

RISCA: Causal Inference and Prediction in Cohort-Based Analyses version 0.9 from CRAN. https://rdrr.io/cran/RISCA/. Accessed 26 Feb 2021

Voskuhl RR, Wang H, Wu TCJ, Sicotte NL, Nakamura K, Kurth F et al (2016) Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15:35–46

CAS  Article  Google Scholar 

Hellwig K, Rockhoff M, Herbstritt S, Borisow N, Haghikia A, Elias-Hamp B et al (2015) Exclusive breastfeeding and the effect on postpartum multiple sclerosis relapses. JAMA Neurol 72:1132–1138

Article  Google Scholar 

Krysko KM, Rutatangwa A, Graves J, Lazar A, Waubant E (2020) Association between breastfeeding and postpartum multiple sclerosis relapses: a systematic review and meta-analysis. JAMA Neurol 77:327–338

Article  Google Scholar 

Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V et al (2019) Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study. Nephrol Dial Transplant 34:703–711

CAS  Article  Google Scholar 

Edan G, Miller D, Clanet M, Confavreux C, Lyon-Caen O, Lubetzki C et al (1997) Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 62:112–118

CAS  Article  Google Scholar